Acquisition

Pfizer to Acquire FoldRx Pharmaceuticals

September 01, 2010

Lead product candidate tafamidis meglumine in EU Registration
 

Meda acquires Alaven, a US specialty pharma company

August 30, 2010

Strengthens position in the strategic US market
 

Fresenius Medical Care Acquires Peritoneal Dialysis Business from Gambro

August 26, 2010

Fresenius expands its activities in the homecare market in Europe and Asia-Pacific
 

BioMarin Acquires ZyStor Therapeutics, Inc.

August 17, 2010

ZyStor's lead product candidate is ZC-701
 

Medtronic Signs Agreement to Acquire Osteotech

August 17, 2010

Acquisition Will Expand Product Offering, Pipeline and New Markets for Biologics Business
 

Cypress Bioscience Responds to Unsolicited, Non-Binding Proposal and Recent Letter From Ramius LLC

August 06, 2010

Proposal thoroughly review by Board of Directors and financial and legal advisors
 

Victory Pharma Completes Acquisition of Assets of MiddleBrook Pharmaceuticals

August 03, 2010

Company Expands Product Portfolio, Adds Drug Delivery Technology
 

Conatus Pharmaceuticals Acquires Pfizer's Idun Subsidiary

July 30, 2010

Former Idun Management team to expand efforts in liver disease and oncology
 

Lilly Announces Completion of Alnara Acquisition

July 20, 2010

Lilly makes upfront payment of $180 million
 

Endo Pharmaceuticals Completes Acquisition of HealthTronics, Inc.

July 15, 2010

HealthTronics becomes a wholly-owned subsidiary of Endo Pharmaceuticals
 

Radient Pharmaceuticals Enters Into a Letter of Intent to Acquire Provista Diagnostics Inc.

July 13, 2010

Diagnostic technologies will strengthen and complement Radient's core business
 

Lilly to Acquire Alnara Pharmaceuticals

July 02, 2010

Alnara's Pancreatic Enzyme Replacement Therapy, Liprotamase, Currently Under FDA Review
 

Astellas Announces Successful Completion of Tender Offer for Shares of OSI

June 08, 2010

Subsequent Offer Period Has Expired; Merger to be Completed Shortly
 

Grifols to Acquire Talecris Biotherapeutics

June 07, 2010

Acquisition to create a world leading provider of life-saving plasma protein therapies
 

Centocor Ortho Biotech Inc. Acquires RespiVert Ltd.

June 01, 2010

Acquisition strengthens pulmonary focus
 

Bard Announces Agreement to Acquire SenoRx, Inc.

May 05, 2010

SenoRx to be Acquired for approximately $200 million
 

Medtronic Signs Agreement to Acquire ATS Medical

April 29, 2010

Acquisition Will Expand Access to Innovative Treatment Options for Structural Heart Disease
 

VaxGen to Acquire diaDexus in a Stock-for-Stock Merger

April 14, 2010

diaDexus will use cash to fund continued adoption of the PLAC(R) Test
 

PerkinElmer Enters Into Agreement to Acquire Signature Genomic Laboratories, LLC

April 14, 2010

Acquisition brings new diagnostic services to global leader in pre-natal and newborn health screening
 

Cephalon Completes Acquisition of Swiss Pharmaceutical Company Mepha

April 09, 2010

Acquisition Diversifies Global Pharmaceutical Business
 

Fate Therapeutics Expands Stem Cell Modulator Pipeline with Acquisition of Verio Therapeutics

April 08, 2010

Fate Therapeutics forms a Canadian subsidiary
 

Cephalon Completes Acquisition of Ception Therapeutics

April 05, 2010

Acquisition Adds Biologics Asset for Advancement to Phase Three Development
 

Abbott Completes Acquisition of STARLIMS Technologies

March 22, 2010

Abbott pays $123 million for STARLIMS Technologies Ltd
 

Astellas Responds to OSI Pharmaceuticals' Rejection

March 15, 2010

Astellas' All-Cash Offer Provides Immediate, Full Value to OSI Stockholders
 

OSI Pharmaceuticals' Board of Directors Unanimously Rejects Astellas' Unsolicited Tender Offer

March 15, 2010

Board Concludes Offer Does Not Fully Reflect OSI's Fundamental, Intrinsic Value
 

Abbott Enhances Pharmaceutical Pipeline with Acquisition of Facet Biotech

March 09, 2010

Abbott will acquire Facet for $27 per share in cash
 

Astellas Pharma Inc. Offers to Acquire OSI Pharmaceuticals for $52.00 Per Share in Cash

March 01, 2010

Astellas to build a world-class oncology platform
 

Cephalon Exercises its Option to Acquire Ception Therapeutics

February 23, 2010

Ception Delivers Positive Results from a Phase II Study of CINQUIL in Adult Eosinophilic Asthma